Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies.

International journal of molecular sciences - 13 Aug 2021

Pagiatakis Christina, Di Mauro Vittoria

Abstract excerpt

Cardiomyopathies (CMPs) are a heterogeneous group of myocardial diseases accountable for the majority of cases of heart failure (HF) and/or sudden cardiac death (SCD) worldwide. With the recent advances in genomics, the original classification of CMPs on the basis of morphological and functional criteria (dilated (DCM), hypertrophic (HCM), restrictive (RCM), and arrhythmogenic ventricular cardiomyopathy (AVC))...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Effects of Exercise

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Epigenomics

Share to Gene Expression Regulation

Share to Gene Regulatory Networks

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 34445422
DOI: 10.3390/ijms22168721
PMCID: PMC8395924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies.PMID 34445422Read ↗

Epigenetics, Modifiers, and Molecular Noise: Rethinking Pathophysiology in Dilated and Hypertrophic Cardiomyopathies.Semantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.Semantic proximity Read ↗

The genetics of cardiomyopathies: what clinicians should know.Semantic proximity Read ↗

Genetic cardiomyopathies. Lessons learned from humans, mice, and zebrafish.Semantic proximity Read ↗

Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Semantic proximity Read ↗

Dilated Cardiomyopathy: A New Era of TreatmentSemantic proximity Read ↗

Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype.Semantic proximity Read ↗

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.Semantic proximity Read ↗

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction.Semantic proximity Read ↗

Cardiomyopathy in Asian Cohorts: Genetic and Epigenetic InsightsSemantic proximity Read ↗

Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their ModifiersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.